NDC Product
Human Prescription DrugFarxiga NDC 50090-3481
- Generic Name
- Dapagliflozin
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Marketing
- NDA
Active Listing
DAPAGLIFLOZIN
UNII 1ULL0QJ8UC
Substance Identification & Data
This profile provides standardized clinical and technical data for Dapagliflozin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1ULL0QJ8UC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 461432-26-8 and the RxNorm Concept ID (RxCUI) 1488564. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
DAPAGLIFLOZIN
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
1ULL0QJ8UC
The specific atomic composition represented as a molecular structure string.
InChIKey
C21H25ClO6 International Chemical Identifier digital signature for unique molecular identification.
SMILES String
JVHXJTBJCFBINQ-ADAARDCZSA-N Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8886
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
SS-83
Identifier assigned by the United States Adopted Names Council.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[C@H]1([C@H]([C@@H]([C@H]([C@H](c2cc(c(cc2)Cl)Cc3ccc(OCC)cc3)O1)O)O)O)CO
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Dapagliflozin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
DAPAGLIFLOZIN
Common Names & Synonyms
BR1019 COMPONENT DAPAGLIFLOZIN
DAPAGLIFLOZIN [INN]
DAPAGLIFLOZIN [MI]
DAPAGLIFLOZIN [ORANGE BOOK]
DAPAGLIFLOZIN [USAN]
DAPAGLIFLOZIN [VANDF]
DAPAGLIFLOZIN [WHO-DD]
QTERNMET COMPONENT DAPAGLIFOZIN
Brand / Trade Names
DAPAGLIFLOZIN COMPONENT QTERNMET
QTERNMET XR COMPONENT DAPAGLIFLOZIN
Systematic Nomenclature
(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL
D-GLUCITOL, 1,5-ANHYDRO-1-C-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-, (1S)-
Technical Codes
BMS-512148
LYN-045
NDC Products Containing DAPAGLIFLOZIN
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
